Aurobindo Pharma has informed that the officials of the Company will be participating in the investor / analyst meeting arranged by JP Morgan scheduled on 21st November 2023 at 05:30 pm to 06:30 pm at Hyderabad. The type of the meeting is In-person (investor group). No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions.
The above information is a part of company’s filings submitted to BSE.